Primary Menu

Education, Events, Publication

Funding & Recognition

Exploring Novel PI3K-AKT-mTOR Therapy Inhibition as a Treatment for BRAF-mutant Melanoma

Semester: Fall 2022

Presentation description

Despite emerging therapies, melanoma progression and metastasis is the leading cause of death for skin cancer patients. BRAF-mutant melanoma is found in 50% of melanoma cases and is a therapeutically challenging malignancy due to the resistance patients experience to target therapies. My research explores PI3K-AKT-mTOR treatments to find pharmacological inhibitors that are safe and effective at combating BRAF-mutant melanoma.

Presenter Name: Ashley Thompson

Presentation Type: Poster
Presentation Format: Virtual
Presentation #26
College: Science
Research Mentor: Gennie Parkman
Physical Location or Zoom link:

Download Poster